Arbutus Biopharma | Investor Presentation Deck | 25 slides · page 11 of 25
The slide outlines the study design for cohorts E through K in Part 3 of the trial.
Pitch deck · appendix_methodology · analyze_data · balanced density
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 5
process bullet paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.